SLS
Stock·OPENNYSE/NASDAQSELLAS Life Sciences Group — Clinical-stage oncology biotech developing cancer immunotherapies.
Price
13.95
24H
—
Volume 24h
$77.65K
OI (USD)
$484.47K
Market Cap
$2.73B
| Exchange | Symbol | Mark | Index | Basis | FundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume. | Volume 24h | Vol % | OI (USD) | Live |
|---|---|---|---|---|---|---|---|---|---|
 | SLSSTOCK_USDT | 13.95 | 13.88 | +50.4 bps | --:--:---0.0146%(-15.99% ann) | $77.65K | 100.0% | $484.47K | 71d |